| Code | 1539E | ||||||||||
| MA number | 85/0197/22-S | ||||||||||
| Product Form: | tbl flm 150x500 mg (blis.PVC/PVDC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | STADA Arzneimittel AG, Germany | ||||||||||
| Therapeutic Class: | 85 - VENOPHARMACA, ANTIVARICOSA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 05.08.2022 |
| Validity: | 05.08.2027 |
| SPC: |
SPC_Diosmin STADA 500 mg tbl flm_01.2023.pdf
|
| PIL: |
PIL_Diosmin STADA 500 mg tbl flm_Rx_01.2023.pdf
|
| PIL: |
PIL_Diosmin STADA 500 mg tbl flm_OTC_01.2023.pdf
|
| Safety feature | Unknown |
| Data update: | 17.01.2023 |
